These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 7526916)
21. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors. Mishra S; Mathur R; Hamburger AW Lymphokine Cytokine Res; 1994 Apr; 13(2):77-83. PubMed ID: 8061118 [TBL] [Abstract][Full Text] [Related]
22. Tyrosine kinase inhibitors attenuate "capacitative" Ca2+ influx in rat pancreatic acinar cells. Yule DI; Kim ET; Williams JA Biochem Biophys Res Commun; 1994 Aug; 202(3):1697-704. PubMed ID: 8060359 [TBL] [Abstract][Full Text] [Related]
23. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines. Bergamaschi G; Rosti V; Danova M; Ponchio L; Lucotti C; Cazzola M Leukemia; 1993 Dec; 7(12):2012-8. PubMed ID: 8255101 [TBL] [Abstract][Full Text] [Related]
24. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells. Agbotounou WK; Levitzki A; Jacquemin-Sablon A; Pierre J Mol Pharmacol; 1994 May; 45(5):922-31. PubMed ID: 7514714 [TBL] [Abstract][Full Text] [Related]
25. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability. Ramdas L; McMurray JS; Budde RJ Cancer Res; 1994 Feb; 54(4):867-9. PubMed ID: 7508821 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity. Wang WY; Hsieh PW; Wu YC; Wu CC Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells. Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601 [TBL] [Abstract][Full Text] [Related]
28. Dissection of T cell antigen receptor signaling using protein tyrosine kinase inhibitors. Baldari CT; Telford JL Eur J Immunol; 1994 May; 24(5):1046-52. PubMed ID: 8181516 [TBL] [Abstract][Full Text] [Related]
29. Activation of signal transduction in platelets by the tyrosine phosphatase inhibitor pervanadate (vanadyl hydroperoxide). Pumiglia KM; Lau LF; Huang CK; Burroughs S; Feinstein MB Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):441-9. PubMed ID: 1530576 [TBL] [Abstract][Full Text] [Related]
30. Thrombin-induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein. Asahi M; Yanagi S; Ohta S; Inazu T; Sakai K; Takeuchi F; Taniguchi T; Yamamura H FEBS Lett; 1992 Aug; 309(1):10-4. PubMed ID: 1511739 [TBL] [Abstract][Full Text] [Related]
31. Protein tyrosine phosphorylation in equine platelets: the effect of stimulation by thrombin and platelet-activating factor (PAF). Dillon AM; Heath MF Equine Vet J; 1995 Nov; 27(6):448-58. PubMed ID: 8565942 [TBL] [Abstract][Full Text] [Related]
32. Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60(c-src) kinase activity. Wijetunge S; Lymn JS; Hughes AD Br J Pharmacol; 2000 Apr; 129(7):1347-54. PubMed ID: 10742290 [TBL] [Abstract][Full Text] [Related]
33. Activation of epidermal growth factor receptor is responsible for pervanadate-induced phospholipase D activation. Kim YR; Cha HY; Lim K; Hwang BD; Hoe KL; Namgung U; Park SK Exp Mol Med; 2003 Apr; 35(2):118-24. PubMed ID: 12754416 [TBL] [Abstract][Full Text] [Related]
34. Synthesis of phosphatidylinositol 3,4-bisphosphate is regulated by protein-tyrosine phosphorylation but the p85 alpha subunit of phosphatidylinositol 3-kinase may not be a target for tyrosine kinases in thrombin-stimulated human platelets. Yatomi Y; Ozaki Y; Satoh K; Kume S Biochim Biophys Acta; 1994 Jun; 1212(3):337-44. PubMed ID: 8199204 [TBL] [Abstract][Full Text] [Related]
35. Platelet shape change induced by thrombin receptor activation. Rapid stimulation of tyrosine phosphorylation of novel protein substrates through an integrin- and Ca(2+)-independent mechanism. Negrescu EV; de Quintana KL; Siess W J Biol Chem; 1995 Jan; 270(3):1057-61. PubMed ID: 7836359 [TBL] [Abstract][Full Text] [Related]
36. Protein tyrosine kinases regulate agonist-stimulated prostacyclin release but not von Willebrand factor secretion from human umbilical vein endothelial cells. Wheeler-Jones CP; May MJ; Morgan AJ; Pearson JD Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):407-16. PubMed ID: 8615807 [TBL] [Abstract][Full Text] [Related]
37. Regulation of eicosanoid biosynthesis in the macrophage. Involvement of protein tyrosine phosphorylation and modulation by selective protein tyrosine kinase inhibitors. Glaser KB; Sung A; Bauer J; Weichman BM Biochem Pharmacol; 1993 Feb; 45(3):711-21. PubMed ID: 8442770 [TBL] [Abstract][Full Text] [Related]
38. Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism. Martinson EA; Scheible S; Greinacher A; Presek P Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):623-8. PubMed ID: 7544577 [TBL] [Abstract][Full Text] [Related]